The novel approach of this peptide represents a significant breakthrough in the handling of the condition. Unlike existing therapies, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatidepeptide146188.pages10.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-77465010